UNRESECTABLE PANCREATIC ADENOCARCINOMA
Clinical trials for UNRESECTABLE PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Light and immune combo takes on tough pancreatic cancer
Disease control Recruiting nowThis study tests a new approach for people with pancreatic cancer that cannot be surgically removed. It combines a light-activated drug (verteporfin) with an immunotherapy (pembrolizumab) and standard chemotherapy. The goal is to see if this combination can shrink tumors better t…
Matched conditions: UNRESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 06:25 UTC
-
Promising new combo aims to slow tough pancreatic cancer
Disease control Recruiting nowThis study tests whether adding a targeted drug called panitumumab to standard chemotherapy can help people with a specific type of advanced pancreatic cancer (KRAS wild-type) live longer. About 94 adults whose cancer has spread or can't be removed will receive either chemo alone…
Matched conditions: UNRESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug TR-002 tested for tough-to-treat cancers
Disease control Recruiting nowThis early-stage study tests a new chemotherapy drug, TR-002, in about 52 people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find the safest dose and check for side effects. The study also looks at whether the drug can shr…
Matched conditions: UNRESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Scientists hunt for hidden subtypes of cancer wasting to personalize treatment
Knowledge-focused Recruiting nowThis study watches 800 people with advanced lung, pancreatic, or colorectal cancer to find different types of cancer-related weight and muscle loss (cachexia). Researchers hope to discover why some patients lose weight differently than others. The goal is to create better, more p…
Matched conditions: UNRESECTABLE PANCREATIC ADENOCARCINOMA
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated May 26, 2026 06:29 UTC